Latest Belimumab Stories
British pharmaceutical giant GlaxoSmithKline (GSK) has acquired US-based Human Genome Sciences (HGS) after tough negotiations saw it raise offers from an initial $2.6 billion in April, putting the final value of the deal at $3.6 billion or $14.25 per share.
WASHINGTON, March 24, 2011 /PRNewswire/ -- Almost 3,000 walkers will celebrate the first drug developed for lupus in more than 50 years during the milestone 5th Annual Walk for Lupus Now! D.C. on Sat., April 16.
Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug BenlystaÂ® (belimumab), approved today by the U.S. Food and Drug Administration. BenlystaÂ®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.
WALTHAM, Mass., Aug.
WALTHAM, Mass., Feb.
SCOTTSDALE, Ariz., Nov.
- An imitative word; an onomatopoetic word.